de Bruin-Weller MS - Search Results

1

Drug survival for ciclosporin A in a long-term daily practice cohort of adult patients with atopic dermatitis.

van der Schaft J, Politiek K, van den Reek JMPA, Christoffers WA, Kievit W, de Jong EMGJ, Bruijnzeel-Koomen CAFM, Schuttelaar MLA, de Bruin-Weller MS. van der Schaft J, et al. Br J Dermatol. 2015 Jun;172(6):1621-1627. doi: 10.1111/bjd.13730. Epub 2015 May 11. Br J Dermatol. 2015. PMID: 25683671

2

Atopy patch testing--a diagnostic tool?

de Bruin-Weller MS, Knol EF, Bruijnzeel-Koomen CA. de Bruin-Weller MS, et al. Allergy. 1999 Aug;54(8):784-91. doi: 10.1034/j.1398-9995.1999.00097.x. Allergy. 1999. PMID: 10485381 Review. No abstract available.

3

Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: the Dutch mite avoidance study.

Oosting AJ, de Bruin-Weller MS, Terreehorst I, Tempels-Pavlica Z, Aalberse RC, de Monchy JG, van Wijk RG, Bruijnzeel-Koomen CA. Oosting AJ, et al. J Allergy Clin Immunol. 2002 Sep;110(3):500-6. doi: 10.1067/mai.2002.126791. J Allergy Clin Immunol. 2002. PMID: 12209102 Clinical Trial.

4

Anti-allergic mattress covers in asthma: to do or not to do?

Rijssenbeek-Nouwens LH, Oosting AJ, Bruijnzeel-Koomen CA, de Bruin-Weller MS. Rijssenbeek-Nouwens LH, et al. Clin Exp Allergy. 2003 Dec;33(12):1613-7. doi: 10.1111/j.1365-2222.2003.01829.x. Clin Exp Allergy. 2003. PMID: 14656344 No abstract available.

5

Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.

Hijnen D, De Bruin-Weller M, Oosting B, Lebre C, De Jong E, Bruijnzeel-Koomen C, Knol E. Hijnen D, et al. J Allergy Clin Immunol. 2004 Feb;113(2):334-40. doi: 10.1016/j.jaci.2003.12.007. J Allergy Clin Immunol. 2004. PMID: 14767451

6

Atopy patch test in patients with atopic eczema/dermatitis syndrome: comparison of petrolatum and aqueous solution as a vehicle.

Oldhoff JM, Bihari IC, Knol EF, Bruijnzeel-Koomen CA, de Bruin-Weller MS. Oldhoff JM, et al. Allergy. 2004 Apr;59(4):451-6. doi: 10.1111/j.1398-9995.2003.00379.x. Allergy. 2004. PMID: 15005770

7

Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis.

Oldhoff JM, Darsow U, Werfel T, Katzer K, Wulf A, Laifaoui J, Hijnen DJ, Plötz S, Knol EF, Kapp A, Bruijnzeel-Koomen CA, Ring J, de Bruin-Weller MS. Oldhoff JM, et al. Allergy. 2005 May;60(5):693-6. doi: 10.1111/j.1398-9995.2005.00791.x. Allergy. 2005. PMID: 15813818 Clinical Trial.

8

[Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].

de Bruin-Weller MS, Bruijnzeel-Koomen CA. de Bruin-Weller MS, et al. Ned Tijdschr Geneeskd. 2005 May 14;149(20):1096-100. Ned Tijdschr Geneeskd. 2005. PMID: 15932135 Review. Dutch.

9

[Corticosteroids and the risk of glaucoma].

Haeck IM, Rouwen AJ, Bruijnzeel-Koomen CA, de Bruin-Weller MS. Haeck IM, et al. Ned Tijdschr Geneeskd. 2006 Mar 11;150(10):583-4; author reply 584. Ned Tijdschr Geneeskd. 2006. PMID: 16566427 Dutch. No abstract available.

10

Modulation of the atopy patch test: tacrolimus 0.1% compared with triamcinolone acetonide 0.1%.

Oldhoff JM, Knol EF, Laaper-Ertmann M, Bruijnzeel-Koomen CA, de Bruin-Weller MS. Oldhoff JM, et al. Allergy. 2006 May;61(5):622-8. doi: 10.1111/j.1398-9995.2006.01075.x. Allergy. 2006. PMID: 16629794 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

223 results

Search Page

Filters